ランキング価格はじめての方へ
  1. 米国企業
  2. Enstar Group LTD

Enstar Group LTDESGR

時価総額
$49.2億
PER
4.4倍
サマリーテーブルに戻る
損益計算書バランスシートキャッシュフロー
2012年
12月31日		2013年
12月31日		2014年
12月31日		2015年
12月31日		2016年
12月31日		2017年
12月31日		2018年
12月31日		2019年
12月31日		2020年
12月31日		2021年
12月31日		2022年
12月31日		2023年
12月31日
Net income (loss)192224227210304332-2129281,727488-9451,218
Net earnings from discontinued operations, net of income taxes----1211--16---
Realized losses (gains) on sale of investments7471---------135-65
Realized losses on investments----------58--
Variable Interest Entity, Primary Beneficiary-----------6
Unrealized losses (gains) on investments---------178-1,479528
Unrealized (gains) losses on investments-----------114
Depreciation and other amortization11655353233366074497
Amortization of net deferred charge assets----------80106
Amortization of net deferred charge assets----------80106
Depreciation and other amortization11655353233366074497
(Income) losses from equity method investments------425623993-7413
Net gain on Enhanzed Re novation-----------275
Sales and maturities of trading securities2,4692,6802,9743,9133,4075,7434,8025,8293,7926,1752,8401,530
Cash consideration for the Enhanzed Re novation-----------94
Purchases of trading securities2,6192,7142,0884,2643,1017,0245,5924,5912,1393,0641,849492
(Income) losses from equity method investments------425623993-7413
Payments to cover securities sold short---------1,156--
Sales and maturities of trading securities2,4692,6802,9743,9133,4075,7434,8025,8293,7926,1752,8401,530
Proceeds from securities sold short---------534--
Purchases of trading securities2,6192,7142,0884,2643,1017,0245,5924,5912,1393,0641,849492
Net payments for derivative contracts---------94--
Payments to cover securities sold short---------1,156--
Net gain on purchase and sales of subsidiaries---------73--
Proceeds from securities sold short---------534--
Other adjustments-----9-15-12-34-23-30-13-5
Net payments for derivative contracts---------94--
Reinsurance balances recoverable on paid and unpaid losses-667-431-435-40322531268350-52-248-375-142
Funds held258-176-114-35967279127871921,4911,241338
Losses and loss adjustment expenses----2591,3639601,0211,0031,870-151-624
Defendant asbestos and environmental liabilities--------18-141-68-31-40
Insurance and reinsurance balances payable-65---121-158152-1587-300-154-23
Other operating assets and liabilities----151-261245-54-389-514417353
Net gain on purchase and sales of subsidiaries---------73--
Other adjustments-----9-15-12-34-23-30-13-5
Reinsurance balances recoverable on paid and unpaid losses-667-431-435-40322531268350-52-248-375-142
Funds held258-176-114-35967279127871921,4911,241338
Losses and loss adjustment expenses----2591,3639601,0211,0031,870-151-624
Defendant asbestos and environmental liabilities--------18-141-68-31-40
Insurance and reinsurance balances payable-65---121-158152-1587-300-154-23
Other operating assets and liabilities----151-261245-54-389-514417353
Realized losses (gains) on sale of investments7471---------135-65
Realized losses on investments----------58--
Variable Interest Entity, Primary Beneficiary-----------6
Unrealized losses (gains) on investments---------178-1,479528
Unrealized (gains) losses on investments-----------114
Depreciation and other amortization11655353233366074497
Amortization of net deferred charge assets----------80106
Amortization of net deferred charge assets----------80106
Depreciation and other amortization11655353233366074497
(Income) losses from equity method investments------425623993-7413
Net gain on Enhanzed Re novation-----------275
Sales and maturities of trading securities2,4692,6802,9743,9133,4075,7434,8025,8293,7926,1752,8401,530
Cash consideration for the Enhanzed Re novation-----------94
Purchases of trading securities2,6192,7142,0884,2643,1017,0245,5924,5912,1393,0641,849492
(Income) losses from equity method investments------425623993-7413
Payments to cover securities sold short---------1,156--
Sales and maturities of trading securities2,4692,6802,9743,9133,4075,7434,8025,8293,7926,1752,8401,530
Proceeds from securities sold short---------534--
Purchases of trading securities2,6192,7142,0884,2643,1017,0245,5924,5912,1393,0641,849492
Net payments for derivative contracts---------94--
Payments to cover securities sold short---------1,156--
Net gain on purchase and sales of subsidiaries---------73--
Proceeds from securities sold short---------534--
Other adjustments-----9-15-12-34-23-30-13-5
Net payments for derivative contracts---------94--
Reinsurance balances recoverable on paid and unpaid losses-667-431-435-40322531268350-52-248-375-142
Funds held258-176-114-35967279127871921,4911,241338
Losses and loss adjustment expenses----2591,3639601,0211,0031,870-151-624
Defendant asbestos and environmental liabilities--------18-141-68-31-40
Insurance and reinsurance balances payable-65---121-158152-1587-300-154-23
Other operating assets and liabilities----151-261245-54-389-514417353
Net gain on purchase and sales of subsidiaries---------73--
Other adjustments-----9-15-12-34-23-30-13-5
Reinsurance balances recoverable on paid and unpaid losses-667-431-435-40322531268350-52-248-375-142
Funds held258-176-114-35967279127871921,4911,241338
Losses and loss adjustment expenses----2591,3639601,0211,0031,870-151-624
Defendant asbestos and environmental liabilities--------18-141-68-31-40
Insurance and reinsurance balances payable-65---121-158152-1587-300-154-23
Other operating assets and liabilities----151-261245-54-389-514417353
Net cash flows provided by operating activities-187-62---203-343-1601,764---523
Net cash flows provided by operating activities--498-739----2,7863,801257-
Acquisition, net of cash acquired-410-38-110184245-172-206--
Sales of subsidiaries, net of cash previously held---------14-214--
Sales and maturities of available-for-sale securities3541971101438286583442,2603,0852,5022,132
Purchase of available-for-sale securities------102,2124,1815,2332,2951,959
Purchase of other investments198107350355911109017979759101,552911
Proceeds from other investments029105169245233436583595330420530
Other investing activities1-2-1282485-1-1-6-12
Sale of equity method investment--------12--48
Consolidation of the InRe Fund opening cash and restricted cash balances (Note 15)----------574--
Other investing activities1-2-1282485-1-1-6-12
Net cash flows used in investing activities---292487-----2,335-2,573-919-
Consolidation of the InRe Fund opening cash and restricted cash balances (Note 15)----------574--
Net cash flows used in investing activities229-366--157293-826-1,984----148
Dividends on preferred shares------123636363636
Dividends paid to noncontrolling interests6941817-274120155-
Repurchase of shares--------26942163531
Proceeds from (Payments to) Noncontrolling Interests------------294
Issuance of debt, net of issuance costs-370706585718741,1331,071859816494-
Repurchase of shares--------26942163531
Repayment of debt13540199378493912914743679574356-
Issuance of debt, net of issuance costs-370706585718741,1331,071859816494-
Net cash flows (used in) provided by financing activities-234423--83-65753294---116-861
Repayment of debt13540199378493912914743679574356-
Net cash flows (used in) provided by financing activities-234423--83-65753294---116-861
Net cash flows provided by operating activities--------108---
Net cash flows used in investing activities---------130---
Net cash flows from discontinued operations---------22---
EFFECT OF EXCHANGE RATE CHANGES ON FOREIGN CURRENCY CASH, CASH EQUIVALENTS AND RESTRICTED CASH-----14103-0-6416-14
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH----23-106-23073541495-762-500
NET CHANGE IN CASH OF BUSINESSES HELD-FOR-SALE---------139224--
Income Taxes Paid, Net----22131852510316
Interest paid------254951648688
Novation of future policy holder benefits-----------828
Funds held directly managed transferred in exchange on novation of future policy holder benefits-----------949
Other assets / liabilities transferred on novation of future policy holder benefits-----------62
Noncash Losses And Loss Adjustment Expenses Transferred In Connection With Settlement Of Syndicate-----------173
Investments transferred in connection with settlement of participation in Atrium's Syndicate 609-----------173
Debt Securities, Available For Sale, Transfer In Exchange For Assumption Of Liabilities----------508-
Unsettled purchases of available-for-sale securities and other investments-----------5
Removal of equity method investment relating to acquisition of a subsidiary----------412--
Unsettled sales of available-for-sale securities and other investments-----------1
Transfer to Investments---------52--
Receipt of available-for-sale securities as consideration in exchange for assumption of reinsurance contract liabilities-----------113
Contribution to other investments---------481--
Debt Securities, Available For Sale, Transfer In Exchange For Assumption Of Liabilities----------508-
Redemption of other investments---------381--
Removal of equity method investment relating to acquisition of a subsidiary----------412--
Transfer to Investments---------52--
Transfer To Other Investments---------481--
Redemption of other investments---------381--
Settlement of loan receivable as partial consideration for RNCI redemption-----------15
Transfer Of Equity Interest, Consideration For Redeemable Noncontrolling Interest-----------48
Debt Securities, Available For Sale, Transfer In Exchange For Assumption Of Liabilities----------508-
Unsettled purchases of available-for-sale securities and other investments-----------5
Removal of equity method investment relating to acquisition of a subsidiary----------412--
Unsettled sales of available-for-sale securities and other investments-----------1
Transfer to Investments---------52--
Receipt of available-for-sale securities as consideration in exchange for assumption of reinsurance contract liabilities-----------113
Contribution to other investments---------481--
Debt Securities, Available For Sale, Transfer In Exchange For Assumption Of Liabilities----------508-
Redemption of other investments---------381--
Removal of equity method investment relating to acquisition of a subsidiary----------412--
Transfer to Investments---------52--
Transfer To Other Investments---------481--
Redemption of other investments---------381--
Settlement of loan receivable as partial consideration for RNCI redemption-----------15
Transfer Of Equity Interest, Consideration For Redeemable Noncontrolling Interest-----------48
Net income (loss)192224227210304332-2129281,727488-9451,218
Net earnings from discontinued operations, net of income taxes----1211--16---
Realized losses (gains) on sale of investments7471---------135-65
Realized losses on investments----------58--
Variable Interest Entity, Primary Beneficiary-----------6
Unrealized losses (gains) on investments---------178-1,479528
Unrealized (gains) losses on investments-----------114
Depreciation and other amortization11655353233366074497
Amortization of net deferred charge assets----------80106
Amortization of net deferred charge assets----------80106
Depreciation and other amortization11655353233366074497
(Income) losses from equity method investments------425623993-7413
Net gain on Enhanzed Re novation-----------275
Sales and maturities of trading securities2,4692,6802,9743,9133,4075,7434,8025,8293,7926,1752,8401,530
Cash consideration for the Enhanzed Re novation-----------94
Purchases of trading securities2,6192,7142,0884,2643,1017,0245,5924,5912,1393,0641,849492
(Income) losses from equity method investments------425623993-7413
Payments to cover securities sold short---------1,156--
Sales and maturities of trading securities2,4692,6802,9743,9133,4075,7434,8025,8293,7926,1752,8401,530
Proceeds from securities sold short---------534--
Purchases of trading securities2,6192,7142,0884,2643,1017,0245,5924,5912,1393,0641,849492
Net payments for derivative contracts---------94--
Payments to cover securities sold short---------1,156--
Net gain on purchase and sales of subsidiaries---------73--
Proceeds from securities sold short---------534--
Other adjustments-----9-15-12-34-23-30-13-5
Net payments for derivative contracts---------94--
Reinsurance balances recoverable on paid and unpaid losses-667-431-435-40322531268350-52-248-375-142
Funds held258-176-114-35967279127871921,4911,241338
Losses and loss adjustment expenses----2591,3639601,0211,0031,870-151-624
Defendant asbestos and environmental liabilities--------18-141-68-31-40
Insurance and reinsurance balances payable-65---121-158152-1587-300-154-23
Other operating assets and liabilities----151-261245-54-389-514417353
Net gain on purchase and sales of subsidiaries---------73--
Other adjustments-----9-15-12-34-23-30-13-5
Reinsurance balances recoverable on paid and unpaid losses-667-431-435-40322531268350-52-248-375-142
Funds held258-176-114-35967279127871921,4911,241338
Losses and loss adjustment expenses----2591,3639601,0211,0031,870-151-624
Defendant asbestos and environmental liabilities--------18-141-68-31-40
Insurance and reinsurance balances payable-65---121-158152-1587-300-154-23
Other operating assets and liabilities----151-261245-54-389-514417353
Realized losses (gains) on sale of investments7471---------135-65
Realized losses on investments----------58--
Variable Interest Entity, Primary Beneficiary-----------6
Unrealized losses (gains) on investments---------178-1,479528
Unrealized (gains) losses on investments-----------114
Depreciation and other amortization11655353233366074497
Amortization of net deferred charge assets----------80106
Amortization of net deferred charge assets----------80106
Depreciation and other amortization11655353233366074497
(Income) losses from equity method investments------425623993-7413
Net gain on Enhanzed Re novation-----------275
Sales and maturities of trading securities2,4692,6802,9743,9133,4075,7434,8025,8293,7926,1752,8401,530
Cash consideration for the Enhanzed Re novation-----------94
Purchases of trading securities2,6192,7142,0884,2643,1017,0245,5924,5912,1393,0641,849492
(Income) losses from equity method investments------425623993-7413
Payments to cover securities sold short---------1,156--
Sales and maturities of trading securities2,4692,6802,9743,9133,4075,7434,8025,8293,7926,1752,8401,530
Proceeds from securities sold short---------534--
Purchases of trading securities2,6192,7142,0884,2643,1017,0245,5924,5912,1393,0641,849492
Net payments for derivative contracts---------94--
Payments to cover securities sold short---------1,156--
Net gain on purchase and sales of subsidiaries---------73--
Proceeds from securities sold short---------534--
Other adjustments-----9-15-12-34-23-30-13-5
Net payments for derivative contracts---------94--
Reinsurance balances recoverable on paid and unpaid losses-667-431-435-40322531268350-52-248-375-142
Funds held258-176-114-35967279127871921,4911,241338
Losses and loss adjustment expenses----2591,3639601,0211,0031,870-151-624
Defendant asbestos and environmental liabilities--------18-141-68-31-40
Insurance and reinsurance balances payable-65---121-158152-1587-300-154-23
Other operating assets and liabilities----151-261245-54-389-514417353
Net gain on purchase and sales of subsidiaries---------73--
Other adjustments-----9-15-12-34-23-30-13-5
Reinsurance balances recoverable on paid and unpaid losses-667-431-435-40322531268350-52-248-375-142
Funds held258-176-114-35967279127871921,4911,241338
Losses and loss adjustment expenses----2591,3639601,0211,0031,870-151-624
Defendant asbestos and environmental liabilities--------18-141-68-31-40
Insurance and reinsurance balances payable-65---121-158152-1587-300-154-23
Other operating assets and liabilities----151-261245-54-389-514417353
Net cash flows provided by operating activities-187-62---203-343-1601,764---523
Net cash flows provided by operating activities--498-739----2,7863,801257-
Acquisition, net of cash acquired-410-38-110184245-172-206--
Sales of subsidiaries, net of cash previously held---------14-214--
Sales and maturities of available-for-sale securities3541971101438286583442,2603,0852,5022,132
Purchase of available-for-sale securities------102,2124,1815,2332,2951,959
Purchase of other investments198107350355911109017979759101,552911
Proceeds from other investments029105169245233436583595330420530
Other investing activities1-2-1282485-1-1-6-12
Sale of equity method investment--------12--48
Consolidation of the InRe Fund opening cash and restricted cash balances (Note 15)----------574--
Other investing activities1-2-1282485-1-1-6-12
Net cash flows used in investing activities---292487-----2,335-2,573-919-
Consolidation of the InRe Fund opening cash and restricted cash balances (Note 15)----------574--
Net cash flows used in investing activities229-366--157293-826-1,984----148
Dividends on preferred shares------123636363636
Dividends paid to noncontrolling interests6941817-274120155-
Repurchase of shares--------26942163531
Proceeds from (Payments to) Noncontrolling Interests------------294
Issuance of debt, net of issuance costs-370706585718741,1331,071859816494-
Repurchase of shares--------26942163531
Repayment of debt13540199378493912914743679574356-
Issuance of debt, net of issuance costs-370706585718741,1331,071859816494-
Net cash flows (used in) provided by financing activities-234423--83-65753294---116-861
Repayment of debt13540199378493912914743679574356-
Net cash flows (used in) provided by financing activities-234423--83-65753294---116-861
EFFECT OF EXCHANGE RATE CHANGES ON FOREIGN CURRENCY CASH, CASH EQUIVALENTS AND RESTRICTED CASH-----14103-0-6416-14
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH----23-106-23073541495-762-500
Income Taxes Paid, Net----22131852510316
Interest paid------254951648688
Novation of future policy holder benefits-----------828
Funds held directly managed transferred in exchange on novation of future policy holder benefits-----------949
Other assets / liabilities transferred on novation of future policy holder benefits-----------62
Noncash Losses And Loss Adjustment Expenses Transferred In Connection With Settlement Of Syndicate-----------173
Investments transferred in connection with settlement of participation in Atrium's Syndicate 609-----------173
Debt Securities, Available For Sale, Transfer In Exchange For Assumption Of Liabilities----------508-
Unsettled purchases of available-for-sale securities and other investments-----------5
Removal of equity method investment relating to acquisition of a subsidiary----------412--
Unsettled sales of available-for-sale securities and other investments-----------1
Transfer to Investments---------52--
Receipt of available-for-sale securities as consideration in exchange for assumption of reinsurance contract liabilities-----------113
Contribution to other investments---------481--
Debt Securities, Available For Sale, Transfer In Exchange For Assumption Of Liabilities----------508-
Redemption of other investments---------381--
Removal of equity method investment relating to acquisition of a subsidiary----------412--
Transfer to Investments---------52--
Transfer To Other Investments---------481--
Redemption of other investments---------381--
Settlement of loan receivable as partial consideration for RNCI redemption-----------15
Transfer Of Equity Interest, Consideration For Redeemable Noncontrolling Interest-----------48